- Home
- TRIB vs CWD Comparison
TRIB vs CWD Comparison
Compare TRIB & CWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- CWD
- Stock Information
- Founded
- TRIB 1992
- CWD 2009
- Country
- TRIB Ireland
- CWD United States
- Employees
- TRIB N/A
- CWD N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CWD Real Estate
- Sector
- TRIB Health Care
- CWD Finance
- Exchange
- TRIB Nasdaq
- CWD Nasdaq
- Market Cap
- TRIB 5.4M
- CWD 4.5M
- IPO Year
- TRIB N/A
- CWD 2023
- Fundamental
- Price
- TRIB $0.98
- CWD $3.10
- Analyst Decision
- TRIB
- CWD
- Analyst Count
- TRIB 0
- CWD 0
- Target Price
- TRIB N/A
- CWD N/A
- AVG Volume (30 Days)
- TRIB 120.8K
- CWD 254.0K
- Earning Date
- TRIB 11-14-2025
- CWD 11-13-2025
- Dividend Yield
- TRIB N/A
- CWD N/A
- EPS Growth
- TRIB N/A
- CWD N/A
- EPS
- TRIB N/A
- CWD N/A
- Revenue
- TRIB $61,555,000.00
- CWD $32,323,000.00
- Revenue This Year
- TRIB $13.51
- CWD N/A
- Revenue Next Year
- TRIB $13.14
- CWD $56.47
- P/E Ratio
- TRIB N/A
- CWD N/A
- Revenue Growth
- TRIB 8.31
- CWD N/A
- 52 Week Low
- TRIB $0.48
- CWD $1.63
- 52 Week High
- TRIB $3.44
- CWD $48.00
- Technical
- Relative Strength Index (RSI)
- TRIB 43.05
- CWD 36.58
- Support Level
- TRIB $0.88
- CWD $3.04
- Resistance Level
- TRIB $1.10
- CWD $3.35
- Average True Range (ATR)
- TRIB 0.07
- CWD 0.25
- MACD
- TRIB 0.00
- CWD -0.06
- Stochastic Oscillator
- TRIB 42.19
- CWD 4.58
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About CWD CaliberCos Inc.
CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.